NCT04104425 is a clinical trial in Patient Compliance, sponsored by Assiut University.

Who is sponsoring NCT04104425?

NCT04104425 is sponsored by Assiut University.

What condition does NCT04104425 study?

NCT04104425 studies Patient Compliance.

Is NCT04104425 still recruiting?

NCT04104425 is currently completed. Last updated 19 July 2023.

Last reviewed 2023-07-19 · How we verify

NCT04104425

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lactate Level and Gastrointestinal Bleeding

Completed Last updated 19 July 2023

What this trial tests

trial in Patient Compliance in 300 participants. Completed in 15 September 2022.

Timeline

15 January 2020

Primary endpoint
15 September 2022

15 September 2022

Quick facts

Lead sponsor	Assiut University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	300
Start date	15 January 2020
Primary completion	15 September 2022
Estimated completion	15 September 2022
Sites	1 location across Egypt

Conditions studied

Patient Compliance — all drugs for Patient Compliance →

Sponsor

Assiut University

Who can join

18 and older, any sex, with Patient Compliance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acute gastrointestinal bleeding is a common emergency with significant morbidity, mortality, and cost. Appropriate risk stratification of patients presenting with acute gastrointestinal bleeding aids in the triage of patients to determine need for hospital admission and the need for emergency endoscopic intervention. Increased blood lactate levels are common in critically ill patients. Our study will evaluate the usefulness of lactate measurements on resources utilisation ( intensive care unit admission, length of hospital stay) and other patient-oriented outcomes ( need for transfusion and endoscopy) in patients with acute gastrointestinal bleeding.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Patient Compliance

Currently open trials in the same condition.

NCT04656028 — Genetic Testing and Motivational Counseling for FH · NA · active not recruiting
NCT06076512 — Pain Clinic Provides Public Health Safety · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04104425 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 19 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04104425.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing